Genetics of Parkinson's disease
β Scribed by R. C. Duvoisin
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 59 KB
- Volume
- 7
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Over the last few years, several genes for monogenic forms of Parkinson's disease (PD) have been mapped and/or cloned. Mutations have been identified in the gene for alpha-synuclein in rare families with dominant PD, indicating that aggregation of this protein in Lewy bodies is probably a crucial st
iology was found. Our case documents the occurrence of this unusual myoclonus physiology in biopsy-proven Lafora disease. Indeed, the movement disorder neurophysiology evaluation was more useful in terms of defining a myoclonus physiology than routine EEG. Wilkins and colleagues 4 first described t
## Abstract Parkinson's disease (PD) is a common neurodegenerative disorder of adulthood characterized clinically by rigidity, bradykinesia, resting tremor, and postural instability. The annual incidence of PD ranges between 16 and 19 individuals per 100,000 (Twelves et al., Mov Disord 2003;18:19β3
Genetic analysis is changing our view of Parkinson's disease: not only is it challenging the long-cherished views about the diagnosis of the disease, it is also starting to suggest a biochemical pathway to disease pathogenesis. These developments are reviewed in the context of three known (synuclein
## Abstract Oxidative stress reactions may contribute to the pathogenesis of Parkinson's disease (PD). The superoxide dismutases potentially play significant roles in PD by detoxifying superoxide radical. We developed genomic DNA and cDNAβbased sequencing assays to identify genetic variants in the